Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Taisho discloses agent for cerebrovascular disorders

Nov. 8, 1996

Mitsubishi reports cathepsin B/calpain inhibitors

Nov. 8, 1996

Histamine H3 receptor ligands described by INSERM/Bioprojet

Nov. 8, 1996

5-HT1A receptor agonists from Sankyo

Nov. 8, 1996

Yoshitomi describes compounds for anxiety and epilepsy

Nov. 8, 1996

MAb for diagnosis of malignant tumors

Nov. 8, 1996

Squalene synthase inhibitors reported by RPR

Nov. 8, 1996

Yamanouchi discloses hypocholesterolemic agents

Nov. 8, 1996

RGL protein for treatment of ras-related cancers

Nov. 8, 1996

Novel tumor vaccine claimed by Boehringer Ingelheim

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...